Study of Tenecteplase (TNK) in Acute Ischemic Stroke (TNK-S2B)
National Institute of Neurological Disorders and Stroke (NINDS)
Clinical Coordinating Center, Department of Neurology, University of Virginia Health System

      The purpose of this study is to determine which of 3 different doses of tenecteplase (TNK) is
      better for treating stroke patients and if TNK offers an advantage over currently available
      treatment with tissue plasminogen activator (tPA).
    
Drug